Search by Drug Name or NDC

    NDC 00169-4132-97 Ozempic 1.34 mg/mL Details

    Ozempic 1.34 mg/mL

    Ozempic is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is SEMAGLUTIDE.

    Product Information

    NDC 00169-4132
    Product ID 0169-4132_7f4b992f-d010-4e6a-a475-d7133df0ebff
    Associated GPIs 2717007000D210
    GCN Sequence Number 077985
    GCN Sequence Number Description semaglutide PEN INJCTR 0.25 OR .5 SUBCUT
    HIC3 C4I
    HIC3 Description ANTIHYPERGLY,INCRETIN MIMETIC(GLP-1 RECEP.AGONIST)
    GCN 44163
    HICL Sequence Number 044675
    HICL Sequence Number Description SEMAGLUTIDE
    Brand/Generic Brand
    Proprietary Name Ozempic
    Proprietary Name Suffix n/a
    Non-Proprietary Name semaglutide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 1.34
    Active Ingredient Units mg/mL
    Substance Name SEMAGLUTIDE
    Labeler Name Novo Nordisk
    Pharmaceutical Class GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209637
    Listing Certified Through n/a

    Package

    NDC 00169-4132-97 (00169413297)

    NDC Package Code 0169-4132-97
    Billing NDC 00169413297
    Package 1 SYRINGE, PLASTIC in 1 CARTON (0169-4132-97) / 1.5 mL in 1 SYRINGE, PLASTIC (0169-4132-90)
    Marketing Start Date 2017-12-06
    NDC Exclude Flag N
    Pricing Information N/A